Tirzepatide is a dual GIP and GLP-1 receptor agonist , meaning it mimics two important gut hormones involved in metabolic regulation: After you eat, these hormones: Tirzepatide activates these receptors in the pancreas, gut, brain, and fatty tissues, leading to significant improvements in blood sugar control and weight loss
People tend to eat fewer calories without feeling deprived
Anti-infection Antibody-Drug Conjugate/ADC Related Apoptosis Autophagy Cell Cycle/DNA Damage Cytoskeleton Epigenetics GPCR/G Protein Immunology/Inflammation JAK/STAT Signaling MAPK/ERK Pathway Membrane Transporter/Ion Channel Metabolic Enzyme/Protease Neuronal Signaling NF-B PI3K/Akt/mTOR PROTAC Protein Tyrosine Kinase/RTK Stem Cell/Wnt TGF-beta/Smad Vitamin D Related/Nuclear Receptor Others Hot Products Compound Screening Libraries Recombinant Proteins Life Science Kits Oligonucleotides Isotope-Labeled Compounds Natural Products Fluorescent Dyes Peptides Inhibitory Antibodies Biochemical Assay Reagents Antibodies Enzymes Reference Standards Induced Disease Models Products GMP Small Molecules Click Chemistry Adjuvants Lipids Saccharides Hot Topics More Restoring Immune Tolerance: New Insights into Autoimmune Disease Research 2026-07-22 Beyond GLP-1: Reprogramming Metabolism Through Next-Generation Therapeutics 2026-07-16 Beyond Traditional Virtual Screening: New Perspectives on AI-Driven Drug Discovery 2026-07-09 Beyond G12C: Emerging Frontiers in KRAS-Targeted Cancer Research 2026-07-02 Nature
Book to learn more today!
Conclusions The whole range of primary genetic astrocytopathies is yet to be fully characterised
We do not publish specific dosing information here because dosing is always individualized and should be determined by your healthcare provider
